Back to the Top 100

No. 47 Investors

Morgan Cheatham

Partner, Bessemer Venture PartnersUnited States

Specializes in healthcare investments leveraging machine learning, advanced diagnostics, and precision medicine infrastructure.

Find on LinkedIn

The Signal

He bridges academic clinical training with institutional venture capital, delivering highly analytical research on how machine learning transforms drug discovery pipelines and clinical workflows for health systems.

Who Morgan Cheatham is

Specializes in healthcare investments leveraging machine learning, advanced diagnostics, and precision medicine infrastructure.

He bridges academic clinical training with institutional venture capital, delivering highly analytical research on how machine learning transforms drug discovery pipelines and clinical workflows for health systems.

Loading the full dossier

At a glance

Role
Partner
Organisation
Bessemer Venture Partners
Platforms
LinkedIn, X, Substack
Based in
United States, North America
Influence Score 87editorial estimate, see how it is built
Reach (25% weight)84

Audience size across LinkedIn, X, YouTube, podcasts and newsletters.

Engagement (20% weight)86

How much the audience actually reacts, comments, shares and subscribes.

Credibility (25% weight)90

Clinical, research, operating or investing track record behind the commentary.

Consistency (15% weight)87

Publishing cadence and how reliably they show up with original work.

Industry impact (15% weight)88

Whether decision makers, policy and capital actually move on what they say.

Scores are subjective editorial estimates compiled by our research desk from public profiles and published work. They are opinion, not measurement, and they are not a judgement of any person's character or ability.

Also in Investors

This profile is compiled by our research desk from public sources and is published as editorial commentary. Want a correction, an update, or your profile removed? and see our corrections and removals policy.